main-logo

ICD-10 Code C79.63 | Secondary malignant neoplasm of bilateral ovaries Symptoms, Diagnosis, Billing

Secondary malignant neoplasm of bilateral ovaries refers to the presence of cancerous cells in both ovaries that have metastasized from a primary tumor located elsewhere in the body. This condition is clinically significant as it indicates advanced disease and necessitates comprehensive treatment planning. The ICD-10 Code C79.63 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage patient care and track cancer prevalence.

What is ICD-10 Code C79.63 for Secondary malignant neoplasm of bilateral ovaries?

ICD-10 Code C79.63 represents secondary malignant neoplasm of bilateral ovaries, indicating that cancer has spread to both ovaries from a primary site. This code is used in clinical documentation and billing when a patient presents with metastatic ovarian cancer, ensuring proper identification of the condition for treatment and reimbursement purposes.

ICD-10 Code C79.63 – Clinical Definition and Explanation of Secondary malignant neoplasm of bilateral ovaries

Secondary malignant neoplasm of bilateral ovaries occurs when cancer cells from another part of the body spread to the ovaries. This condition often arises from cancers such as breast, colon, or endometrial cancer. It requires prompt medical attention due to its implications for treatment and prognosis.

Key Clinical Features:

  • Bilateral ovarian masses on imaging studies
  • Ascites or abdominal distension
  • Pelvic pain or discomfort
  • Elevated tumor markers (e.g., CA-125)

ICD-10 Code C79.63 for Secondary malignant neoplasm of bilateral ovaries – SOAP Notes & Clinical Use

ICD-10 Code C79.63 is utilized in SOAP notes to document the presence of secondary malignant neoplasm of bilateral ovaries. It plays a crucial role in capturing patient symptoms, assessment findings, and treatment plans, relevant in both acute and chronic care settings.

What Does ICD-10 Code C79.63 for Secondary malignant neoplasm of bilateral ovaries Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C79.63 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of secondary malignant neoplasm of bilateral ovaries. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C79.63 – Secondary malignant neoplasm of bilateral ovaries

The management of secondary malignant neoplasm of bilateral ovaries often requires hospitalization due to the complexity of treatment. Disease-specific approaches are essential for effective care.

Antibiotic Therapy:

  • Not applicable as this condition is not infectious

Supportive Care:

  • Pain management with analgesics
  • Nutritional support and counseling
  • Psychosocial support services
  • Palliative care options as needed

Infection Control:

  • Standard precautions during treatment
  • Monitoring for signs of infection post-surgery or chemotherapy
  • Patient education on hygiene and care

How to Document Symptoms of Secondary malignant neoplasm of bilateral ovaries (ICD-10 C79.63) in SOAP Notes

Subjective:

  • Patient reports pelvic pain and discomfort
  • History of weight loss and fatigue
  • Complaints of abdominal swelling
  • Previous diagnosis of breast cancer

Objective:

  • Bilateral adnexal masses noted on pelvic ultrasound
  • Elevated CA-125 levels
  • Abdominal tenderness on examination
  • Vital signs stable with no fever
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Secondary malignant neoplasm of bilateral ovaries (ICD-10 Code C79.63)

Assessment:

  • Diagnosis: Secondary malignant neoplasm of bilateral ovaries, severe
  • ICD-10 Code: C79.63
  • Contributing factors: History of breast cancer, advanced stage
  • Potential complications include ascites and pain management issues.

Plan:

  • Initiate chemotherapy regimen as per oncology guidelines
  • Refer to palliative care for symptom management
  • Schedule follow-up imaging in 6 weeks
  • Educate patient on signs of complications and when to seek care.

Treatment & Plan Section for ICD-10 Code C79.63 – Secondary malignant neoplasm of bilateral ovaries

  • Chemotherapy as first-line treatment
  • Consideration of surgical intervention if feasible
  • Nutritional support to manage weight loss
  • Regular follow-up appointments to monitor disease progression

Using ICD-10 Code C79.63 for Secondary malignant neoplasm of bilateral ovaries in Billing & SOAP Note Compliance

  • Ensure accurate documentation of symptoms and findings in SOAP notes
  • Use C79.63 in conjunction with relevant CPT codes for billing
  • Maintain compliance with coding guidelines to support reimbursement
  • Document treatment plans that align with clinical guidelines for justifiable billing

ICD-10 Code C79.63 in Medical Billing and Insurance for Secondary malignant neoplasm of bilateral ovaries

ICD-10 Code C79.63 is critical in medical billing, particularly in hospital and oncology settings.

Billing Notes:

  • Document all relevant clinical findings to support the diagnosis
  • Use C79.63 in the context of treatment plans for accurate billing
  • Ensure that all documentation aligns with payer requirements for reimbursement
  • Include detailed notes on patient history and treatment response.

Common CPT Pairings:

CPT CodeDescription
96413Chemotherapy administration, intravenous, push, single or initial substance/drug
99214Established patient office visit, moderate complexity
58661Laparoscopy, surgical, with bilateral salpingo-oophorectomy

Frequently Asked Questions

Common Questions About Using ICD-10 Code C79.63 for Secondary malignant neoplasm of bilateral ovaries

What are the common symptoms of secondary malignant neoplasm of bilateral ovaries?

Common symptoms include pelvic pain, abdominal swelling, weight loss, and fatigue. Patients may also experience changes in bowel or urinary habits due to the mass effect of the tumors.

How is secondary malignant neoplasm of bilateral ovaries diagnosed?

Diagnosis typically involves imaging studies such as ultrasound or CT scans, along with laboratory tests to check tumor markers like CA-125. A biopsy may be performed to confirm the diagnosis.

What treatment options are available for this condition?

Treatment options may include chemotherapy, surgical intervention, and palliative care. The specific approach depends on the extent of disease and the patient's overall health.

Is secondary malignant neoplasm of bilateral ovaries curable?

The prognosis varies based on the primary cancer type and stage at diagnosis. While it may not be curable, treatment can help manage symptoms and improve quality of life.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved